KI-Tool sagt die Ausbreitung von Krebs voraus, bevor sie beginnt

„“The great novelty of our tool, called ‘Mangrove Gene Signatures (MangroveGS)’, is that it exploits dozens, even hundreds, of gene signatures. This makes it particularly resistant to individual variations,” said lead author Aravind Srinivasan from UNIGE.

That design choice matters because cancer is messy. Tumors vary between patients, between tumor types, and even within the same tumor.

A tool that relies on one “signature” can be brittle. A tool that looks at many signals at once can sometimes be more robust.

In tests, MangroveGS predicted metastasis and colon cancer recurrence with close to 80% accuracy and performed better than existing approaches.“